Investing.com - Financial Markets Worldwide
👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

U.S. administers 273.5 million doses of COVID-19 vaccines: CDC

Published 05/16/2021, 02:33 PM
Updated 05/16/2021, 02:35 PM
© Reuters. FILE PHOTO: Sandra Cervantes, 14, receives a coronavirus disease (COVID-19) vaccination at a vaccine clinic for newly eligible 12 to 15-year-olds in Pasadena, California, U.S., May 14, 2021. REUTERS/Lucy Nicholson/File Photo
JNJ
-
MRNA
-

(Reuters) - The United States has administered 273,545,207 doses of COVID-19 vaccines in the country as of Sunday morning and distributed 344,503,495 doses, the U.S. Centers for Disease Control and Prevention (CDC) said.

Those figures are up from the 270,832,342 vaccine doses the CDC said had gone into arms by Saturday out of 344,503,395 doses delivered.

© Reuters. FILE PHOTO: Sandra Cervantes, 14, receives a coronavirus disease (COVID-19) vaccination at a vaccine clinic for newly eligible 12 to 15-year-olds in Pasadena, California, U.S., May 14, 2021. REUTERS/Lucy Nicholson/File Photo

The agency said 157,485,596 people had received at least one dose, while 123,282,685 people are fully vaccinated.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6 a.m. ET (1000 GMT) on Sunday.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.